After administration of nanoparticle (NP) into biological fluids, an NP–protein complex is
formed, which represents the “true identity” of NP in our body. Hence, protein–NP interaction …

Many types of nanoparticles (NPs) are tested for use in medical products, particularly in
imaging and gene and drug delivery. For these applications, cellular uptake is usually a …

Nanomaterials hold promise as multifunctional diagnostic and therapeutic agents. However,
the effective application of nanomaterials is hampered by limited understanding and control …

The importance of the protein corona formed around nanoparticles upon entering a
biological fluid has recently been highlighted. This corona is, when sufficiently long-lived …

Monoclonal antibodies are used in numerous therapeutic and diagnostic applications;
however, their efficacy is contingent on specificity and avidity. Here, we show that …

The non-specific interaction between nanoparticles (NPs) and plasma proteins occurs
immediately after NPs enter the blood, resulting in the formation of the protein corona that …

Nanoparticles are suitable platforms for cancer targeting and diagnostic applications.
Typically, less than 10% of all systemically administered nanoparticles accumulate in the …

The protein–nanoparticle (NP) interface is a current frontier of multiple disciplines, full of
challenges and opportunities. The unique behaviors of nanomaterials (NMs) bring many …

Biodegradable micro/nanoparticles generated from PLGA have recently attracted attention
due to their clinically proven biocompatibility, especially for immunization purposes. These …

The potential applications of nanomaterials as drug delivery systems and in other products
continue to expand. Upon introduction into physiological environments and driven by …